Navigation Links
Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
Date:11/5/2008

CAMBRIDGE, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, announced today that Carlos A. Riva, President and Chief Executive Officer, will speak at the upcoming Credit Suisse Alternative Energy Conference as part of a panel discussion on biofuels and the future of transportation. The panel is scheduled from 11:00 - 12:00 p.m. ET on Wednesday, November 12, 2008 and will take place in New York City.

About Verenium

Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and health and nutrition markets. The Company possesses integrated, end-to-end capabilities in pre-treatment, novel enzyme development, fermentation, engineering, and project development and is moving rapidly to commercialize its proprietary technology for the production of ethanol from a wide array of feedstocks, including sugarcane bagasse, dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities exist for the Company for products derived from the production of low-cost, biomass-derived sugars.

Verenium's Specialty Enzyme business harnesses the power of enzymes to create a broad range of specialty products to meet high-value commercial needs. Verenium's world class R&D organization is renowned for its capabilities in the rapid screening, identification, and expression of enzymes-proteins that act as the catalysts of bi
'/>"/>

SOURCE Verenium Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
2. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
3. Verenium Corporation to Present at the Pacific Growth Equities 2007 Clean Technology & Industrial Growth Conference
4. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
5. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
6. Verenium Reports Financial Results for the First Quarter 2008
7. Verenium Appoints John F. Dee to Board of Directors
8. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
9. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
10. Verenium Corporation to Announce Third Quarter 2008 Financial Results
11. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRN...g publisher of scientific, medical and technical p...aunch of Embase, its comprehensive biomedical,data...rom more than 7,000,active, peer reviewed journals...the advancement of new biomedical,and pharmaceutic...
(Date:11/27/2009)... A mechanised blue dye test alternative i...uality assurance one step closer for pharma-compan...sting machine developed by Sepha for use with b...several local and global pharma-companies such as ... assurance and productivity improvements on the pa...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. 25 /PRN...ainful year. Not so for BodyLogicMD. The nation,s...sicians specializing exclusively in medically supe...er of physicians in its network since Novemb...ogress to add more physician-owned centers, includ...
(Date:11/24/2009)... available in German . , Whether it,s CD pa...tags (Radio Frequency Identification) are increasi...ke it possible to label objects or goods and ident...ropriate scanner can read and process the data con...o goods under production conditions of up to 100 d...
Breaking Biology Technology:Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Intelligence inside metal components 2
...tiles,Transnational Corp. today announced the expa...ratories and Clinical Development Services (CDS) u...ess in China., The new consolidated Quintiles Chi...space, is located at Sun Dong Ann Plaza in Beijing...e Peking Union Medical College,Hospital (PUMCH). T...
...drug,and diagnostic discovery company, announced t...gic partnership with bioMerieux in the field of,ca..., ExonHit will gain,commercial rights on the diagn...ioMerieux will have a greater flexibility to initi...field., The partnership, initiated in October 200...
..., the global,leader in cold chain visibility solut...ility - A Discussion and Review of Industry,Implem...estment" at IQPC,(International Quality & Producti...ium. Sensitech is a wholly owned subsidiary of Car...SE: UTX )., (Logo: http://www.newscom.com/cgi-b...
Other Biology Technology:Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility 2ExonHit and bioMerieux Amend Their Strategic Partnership 2ExonHit and bioMerieux Amend Their Strategic Partnership 3Sensitech to Sponsor Panel Session at IQPC Cool Chain Europe 2008 2Sensitech to Sponsor Panel Session at IQPC Cool Chain Europe 2008 3
(Date:11/26/2009)... (methicillin-resistant Staphylococcus Aureus ) a...lation as low-temperature plasma prototype devices...d unfailing bactericidal cocktails. , Two protot... disinfection of healthy skin (e.g. hands and feet...n pose a lethal threat; and another to shoot bacte...
(Date:11/25/2009)...ns, Ga. Bacteria don,t have easy lives. In additi...gs, they have natural enemies called bacteriophage...ery two days. , Still, bacteria and another cla...red in extreme environments such as deep-sea volca...cause they have a built-in defense system that hel...
(Date:11/25/2009)...SON, WI, NOVEMBER 25, 2009 Soil is the linchpin o...d hydrosphere meet. Despite that, many students se... nothing more. Soil science educators are challeng...c recognize the critical importance of soil in the... science and earth science teachers at University ...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 1Diamyd 28R 29 Phase III Study Approved for Younger Patients in the US 12511 2Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 1Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 2Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 3Two Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride 48149 4One of Womens Best Kept Secrets is Now Available in the Mens Department 48145 1One of Womens Best Kept Secrets is Now Available in the Mens Department 48145 2
... advance in the study of the complex receptors and...rs at the University of California, San Diego (UCS...ling pathways that impact activation of a receptor...o the thrombosis that occurs in heart attacks and ...the signaling pathway that regulates activation of...
...ave been exposed to biological or chemical weapons...IT researchers who are helping to develop a tiny d.... , By tweaking the design of a tiny pump, researc...anotechnologies have taken a major step towards ma...ortable, so the tiny device can perform hundreds o...
...th,s Vaccine 1 highlights the huge gap between cur...commendations endorsed by the European Union. Curr...ations are receiving seasonal influenza vaccine in...lisations and mortality. , For the first time, r...able European public health officials to visualise...
Other Biology News:UCSD researchers create roadmap to integrin activation 2UCSD researchers create roadmap to integrin activation 3MIT designs portable 'lab on a chip' 2MIT designs portable 'lab on a chip' 3First-time analysis reveals millions of Europeans left at risk from influenza 2First-time analysis reveals millions of Europeans left at risk from influenza 3
Normal Rat Serum from Equitech-Bio
...s that have mutations in both the thioredoxin redu..., which greatly enhances disulfide bond formation ...on in Origami(DE3) yielded 10-fold more active pro...ession levels were similar (1). Origami hosts are ...
... provides tightly regulated control of exogenous g...f repeated on/off expression kinetics. This degree...eraction between the GenoStat Ligand and the chime...ssion levels are easily manipulated higher or lowe...
CometSlide from R&D Systems
Biology Products: